Related Experiment Video
Updated: Jul 3, 2026
07:38
DNA Polymerase Activity Assay Using Near-infrared Fluorescent Labeled DNA Visualized by Acrylamide Gel Electrophoresis
Published on: October 6, 2017
DNA polymerases as therapeutic targets.
1Department of Pharmacology, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA. ajb15@case.edu
Biochemistry
|July 23, 2008
Summary
Targeting DNA replication by inhibiting DNA polymerases offers therapeutic potential for cancer and infections. This review summarizes agents that block polymerase activity, including nucleoside analogues, for treating diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Uncontrolled DNA replication is implicated in various diseases, including cancer and infections.
- DNA polymerases are key enzymes in DNA replication and thus represent critical therapeutic targets.
- Inhibiting DNA polymerase activity offers a strategy for developing novel treatments.
Purpose of the Study:
- To review therapeutic agents targeting DNA polymerase activity.
- To discuss the mechanism of action, structure-activity relationships, and resistance of polymerase inhibitors.
- To explore new therapeutic approaches targeting DNA repair and translesion synthesis polymerases.
Main Methods:
- Literature review of therapeutic agents targeting DNA polymerases.
- Discussion of biological function and mechanism of polymerases.
- Analysis of nucleoside and non-nucleoside inhibitors for antiviral and anticancer applications.
Main Results:
- Nucleoside analogues are effective inhibitors of viral and cancer-associated polymerases.
- Understanding structure-activity relationships aids in rational drug design.
- Resistance mechanisms and toxicity are critical considerations for therapeutic development.
Conclusions:
- Inhibitors of DNA polymerases are valuable therapeutic agents for viral infections and cancer.
- Targeting DNA repair and translesion synthesis polymerases presents a promising new avenue for anticancer therapy.
- Further research into selective polymerase inhibition can lead to more effective and safer treatments.
Related Concept Videos
01:31Proofreading
Synthesis of new DNA molecules is carried out by the enzyme DNA polymerase, which adds nucleotides on the daughter strand complementary to the template DNA strand. DNA polymerase has a higher affinity to add the correct base and ensures fidelity during DNA replication. Furthermore, it exhibits proofreading activity during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.
Errors During Replication are Corrected by the DNA Polymerase Enzyme
Errors During Replication are Corrected by the DNA Polymerase Enzyme
01:43Proofreading
Synthesis of new DNA molecules starts when DNA polymerase links nucleotides together in a sequence that is complementary to the template DNA strand. DNA polymerase has a higher affinity for the correct base to ensure fidelity in DNA replication. The DNA polymerase furthermore proofreads during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.Errors during Replication Are Corrected by the DNA Polymerase EnzymeGenomic DNA is synthesized in...
02:10Translesion DNA Polymerases
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
00:55DNA Helicases
DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...